"
Intramuscular Diffusion Status of Risperidone and Aripiprazole Long Acting Injectable (LAI) by Ultrasonography"
written by Yuko Yasuhara, Tetsuya Tanioka, Kensaku Takase, Kazushi Motoki, Chie Watari, Koichi Makiguchi, Asumi Atsuta, Rozzano C. Locsin,
published by
Open Journal of Psychiatry,
Vol.6 No.2, 2016
has been cited by the following article(s):
|
[1]
|
Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers
British Journal of Clinical Pharmacology,
2022
DOI:10.1111/bcp.14977
|
|
|
|
|
[2]
|
Evaluations of echogenicity in gluteal muscle in patients with schizophrenia treated with second generation long-acting injectable antipsychotics: risperidone or aripiprazole
Neurosonology,
2018
DOI:10.2301/neurosonology.31.7
|
|
|
|
|
[3]
|
Evaluations of muscle echogenicities in patients treated with second generation long acting injectable antipsychotics
Neurosonology,
2017
DOI:10.2301/neurosonology.30.13
|
|
|
|
|
[4]
|
Comparison of Gluteal Muscle Intramuscular Injection Sites of Japanese Healthy Subjects: Considerations for Optimal Insertion of Injection Needle Length
Open Journal of Psychiatry,
2016
DOI:10.4236/ojpsych.2016.62025
|
|
|
|